Trials / Completed
CompletedNCT06941077
A Study to Evaluate the Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants
Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Incyte Corporation · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | INCB057643 | Tablet |
Timeline
- Start date
- 2025-05-12
- Primary completion
- 2025-06-03
- Completion
- 2025-06-03
- First posted
- 2025-04-23
- Last updated
- 2025-06-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06941077. Inclusion in this directory is not an endorsement.